SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Synvista Therapeutics Announces Restructuring of Dividend Obligation to Preferred Stockholders and Decision to Delist from NYSE Alternext and Terminate SEC Registration of Common Stock